Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06534983
PHASE2

A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)

Sponsor: Hoffmann-La Roche

View on ClinicalTrials.gov

Summary

The main purpose of the study is to evaluate the efficacy of adjuvant treatment with autogene cevumeran plus nivolumab compared with nivolumab in participants with high risk MIUC. In this study participants will be enrolled in a safety run-in phase to receive autogene cevumeran + nivolumab. This phase will be conducted to monitor and ensure the safety of study participants. After all participants in the safety run-in have been enrolled to receive autogene cevumeran + nivolumab, further participants will be randomized in either autogene cevumeran + nivolumab or the saline + nivolumab arm.

Official title: A Randomized Phase II, Double-blind, Multicenter Study Evaluating the Efficacy and Safety of Autogene Cevumeran Plus Nivolumab Versus Nivolumab as Adjuvant Therapy in Patients With High-risk Muscle-invasive Urothelial Carcinoma

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

362

Start Date

2024-12-09

Completion Date

2027-11-10

Last Updated

2026-04-09

Healthy Volunteers

No

Interventions

DRUG

Autogene Cevumeran

Autogene cevumeran will be administered as an IV infusion per the schedule specified in the arm.

DRUG

Nivolumab

Nivolumab will be administered as an IV infusion per the schedule specified in the arm.

DRUG

Saline

Saline solution for IV infusion.

Locations (107)

Highlands Oncology Group.

Springdale, Arkansas, United States

Kaiser Permanente - Baldwin Park

Baldwin Park, California, United States

City of Hope Cancer Center

Duarte, California, United States

Kaiser Permanente - Los Angeles (N. Vermont)

Los Angeles, California, United States

Kaiser Permanente - Riverside

Riverside, California, United States

University of California San Francisco

San Francisco, California, United States

Yale Cancer Center

New Haven, Connecticut, United States

Georgetown University Medical Center Lombardi Cancer Center

Washington D.C., District of Columbia, United States

Norton Cancer Institute

Louisville, Kentucky, United States

Henry Ford Health System

Detroit, Michigan, United States

Memorial Sloan Kettering Cancer Center Basking Ridge

Basking Ridge, New Jersey, United States

MSK Monmouth

Middletown, New Jersey, United States

MSK Bergen

Montvale, New Jersey, United States

MSK Commack

Commack, New York, United States

MSK Westchester

Harrison, New York, United States

Columbia University Irving Medical Center

New York, New York, United States

Memorial Sloan Kettering Cancer Center

New York, New York, United States

MSK Nassau

Uniondale, New York, United States

Providence Portland Medical Ctr

Portland, Oregon, United States

AHN Cancer Institute ? Allegheny General Hospital

Pittsburgh, Pennsylvania, United States

Rhode Island Hospital

Providence, Rhode Island, United States

Bon Secours - St. Francis Hospital

Greenville, South Carolina, United States

MD Anderson Cancer Center

Houston, Texas, United States

Inova Schar Cancer Institute

Fairfax, Virginia, United States

Fred Hutchinson Cancer Research Center

Seattle, Washington, United States

University of Washington Medical Center

Seattle, Washington, United States

Instituto Alexander Fleming

Buenos Aires, Argentina

Hospital Britanico

Buenos Aires, Argentina

Hospital Italiano

Ciudad Autonoma Buenos Aires, Argentina

Lyell McEwin Hospital

Elizabeth Vale, South Australia, Australia

Box Hill Hospital

Box Hill, Victoria, Australia

Sunshine Hospital

St Albans, Victoria, Australia

UZ Gent

Ghent, Belgium

AZ Groeninge

Kortrijk, Belgium

UZ Leuven Gasthuisberg

Leuven, Belgium

Clinique Ste-Elisabeth

Namur, Belgium

Hospital Moinhos de Vento

Porto Alegre, Rio Grande do Sul, Brazil

Cross Cancer Institute

Edmonton, Alberta, Canada

Princess Margaret Cancer Center

Toronto, Ontario, Canada

Jewish General Hospital

Montreal, Quebec, Canada

McGill University Health Center

Montreal, Quebec, Canada

Aalborg Universitetshospital

Aalborg, Denmark

Aarhus Universitetshospital

Aarhus N, Denmark

Herlev Hospital

Herlev, Denmark

Hopital Claude Huriez

Lille, France

Institut Paoli Calmettes

Marseille, France

Centre Eugene Marquis

Rennes, France

Institut Gustave Roussy

Villejuif, France

Vivantes Klinikum Am Urban

Berlin, Germany

Universitätsklinikum Düsseldorf;Urologische Klinik

Düsseldorf, Germany

Uniklinik Essen

Essen, Germany

Uniklinik-Eppendorf

Hamburg, Germany

Uniklinikum Heidelberg

Heidelberg, Germany

Marien Hospital Herne

Herne, Germany

Universitätsklinikum Jena, Urologische Klinik und Poliklinik

Jena, Germany

Klinikum rechts der Isar der TU München

München, Germany

Klinikum Stuttgart - Katharinenhospital

Stuttgart, Germany

Universitätsklinikum Ulm

Ulm, Germany

Alexandras Hospital

Athens, Greece

Attikon University General Hospital

Athens, Greece

Theageneio Hospital

Thessaloniki, Greece

A.O. Universitaria Ospedale Consorziale Policlinico Di Bari

Bari, Apulia, Italy

Istituto Nazionale Tumori Irccs Fondazione G. Pascale

Naples, Campania, Italy

AZ.Osp S. Orsola ? Malpighi-Reparto di Oncologia Medica

Bologna, Emilia-Romagna, Italy

IFO - Istituto Regina Elena

Rome, Lazio, Italy

Asst Papa Giovanni XXIII

Bergamo, Lombardy, Italy

Istituto Clinico Humanitas

Rozzano, Lombardy, Italy

A.O. Universitaria S. Luigi Gonzaga

Orbassano, Piedmont, Italy

IOV - Istituto Oncologico Veneto - IRCCS

Padova, Veneto, Italy

A.O.U di Verona Policlinico G.B. Rossi

Verona, Veneto, Italy

Hospital Civil de Guadalajara Fray Antonio Alcalde

Guadalajara, Jalisco, Mexico

CUAN Hospital

San Pedro Garza García, Nuevo León, Mexico

Erasmus MC

Rotterdam, Netherlands

St. Antonius locatie Leidsche Rijn

Utrecht, Netherlands

Akershus universitetssykehus

Lørenskog, Norway

Centrum Onkologii im. Prof. Franciszka ?ukaszczyka

Bydgoszcz, Poland

Szpital Wojewodzki im. M. Kopernika w Koszalinie

Koszalin, Poland

Centrum Onkologii Ziemi Lubelskiej im. sw. Jana z Dukli

Lublin, Poland

Szpital Kliniczny Ministerstwa Spraw Wewn?trznych i Administracji z Warmi?sko-Mazurskim Centrum Onkologii w Olsztynie

Olsztyn, Poland

Radomskie Centrum Onkologii

Radom, Poland

AIDPORT Sp. z o. o.

Skórzewo, Poland

Narodowy Instytut Onkologii im. M. Sklodowskiej-Curie

Warsaw, Poland

Seoul National University Bundang Hospital

Seongnam-si, South Korea

Seoul National University Hospital

Seoul, South Korea

Severance Hospital, Yonsei University Health System

Seoul, South Korea

Asan Medical Center

Seoul, South Korea

Samsung Medical Center

Seoul, South Korea

Hospital Universitario Son Espases

Palma de Mallorca, Balearic Islands, Spain

ICO L'Hospitalet

L'Hospitalet de Llobregat, Barcelona, Spain

Vall d'Hebron Institute of Oncology (VHIO), Barcelona

Sant Andreu de la Barca, Barcelona, Spain

Complejo Hospitalario Universitario de Santiago (CHUS)

Santiago de Compostela, LA Coruna, Spain

Hospital Clinico San Carlos

Madrid, Spain

Hospital Universitario La Paz

Madrid, Spain

Hospital Universitario Virgen del Rocio

Seville, Spain

Instituto Valenciano Oncologia

Valencia, Spain

Hospital General Universitario de Valencia

Valencia, Spain

Hospital Clinico Universitario Lozano Blesa

Zaragoza, Spain

Sahlgrenska University Hospital

Gothenburg, Sweden

Skånes Onkologiska Klinik, Universitetssjukhuset

Lund, Sweden

Chang Gung Medical Foundation - Kaohsiung

Kaohsiung City, Taiwan

National Taiwan Uni Hospital

Taipei, Taiwan

Taipei Veterans General Hospital

Taipei, Taiwan

Clatterbridge Cancer Centre

Bebington, United Kingdom

Royal Devon and Exeter Hospital

Exeter, United Kingdom

Barts & London School of Med;Medical Oncology

London, United Kingdom

Royal Preston Hosptial

Preston, United Kingdom

Southampton General Hospital

Southampton, United Kingdom